Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

BCMA Protein (AA 2-54, Extracellular Domain) (Fc Tag)

TNFRSF17 Origine: Humain, Souris Hôte: HEK-293 Cells Recombinant >95 % (SDS-PAGE) SDS Active
N° du produit ABIN1344234
  • Antigène Voir toutes BCMA (TNFRSF17) Protéines
    BCMA (TNFRSF17) (Tumor Necrosis Factor Receptor Superfamily, Member 17 (TNFRSF17))
    Type de proteíne
    Recombinant
    Activité biologique
    Active
    Attributs du protein
    Extracellular Domain, AA 2-54
    Origine
    • 38
    • 12
    • 6
    • 6
    • 2
    • 1
    • 1
    Humain, Souris
    Source
    • 40
    • 7
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    HEK-293 Cells
    Purification/Conjugué
    Cette BCMA protéine est marqué à la Fc Tag.
    Application
    SDS-PAGE (SDS)
    Specificité
    Binds human and mouse BAFF and APRIL.
     Réactivité croisée
    Humain, Souris
    Attributs du produit
    The extracellular domain of human BCMA (aa 2-54) is fused at the C-terminus to the Fc portion of human IgG1.
    Pureté
    >95 % (SDS-PAGE)
    niveau d'endotoxine
    <0.01EU/μg purified protein (LAL test, Lonza).
    Top Product
    Discover our top product TNFRSF17 Protéine
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Commentaires

    Blocks the binding of BAFF and APRIL to their receptors BCMA and TACI, inhibiting BAFF- and APRIL-mediated B cell activation.

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Reconstitute with 50 μL sterile water.
    Concentration
    Lot specific
    Buffer
    Lyophilized. Contains PBS.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Short Term Storage: +4°C
    Long Term Storage: -20°C
    Stable for at least 6 months after receipt when stored at -20°C.
    Date de péremption
    6 months
  • Huard, Tran, Benkhoucha, Manzin-Lorenzi, Santiago-Raber: "Selective APRIL blockade delays systemic lupus erythematosus in mouse." dans: PLoS ONE, Vol. 7, Issue 2, pp. e31837, (2012) (PubMed).

    Huard, Arlettaz, Ambrose, Kindler, Mauri, Roosnek, Tschopp, Schneider, French: "BAFF production by antigen-presenting cells provides T cell co-stimulation." dans: International immunology, Vol. 16, Issue 3, pp. 467-75, (2004) (PubMed).

    Huard, Schneider, Mauri, Tschopp, French: "T cell costimulation by the TNF ligand BAFF." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 167, Issue 11, pp. 6225-31, (2001) (PubMed).

    Rennert, Schneider, Cachero, Thompson, Trabach, Hertig, Holler, Qian, Mullen, Strauch, Browning, Ambrose, Tschopp: "A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth." dans: The Journal of experimental medicine, Vol. 192, Issue 11, pp. 1677-84, (2000) (PubMed).

  • Antigène
    BCMA (TNFRSF17) (Tumor Necrosis Factor Receptor Superfamily, Member 17 (TNFRSF17))
    Autre désignation
    BCMA (TNFRSF17 Produits)
    Synonymes
    TNFRSF17 Protein, BCM Protein, BCMA Protein, CD269 Protein, TNFRSF13A Protein, Tnfrsf13 Protein, Tnfrsf13a Protein, TNF receptor superfamily member 17 Protein, tumor necrosis factor receptor superfamily, member 17 Protein, Tnfrsf17 Protein, TNFRSF17 Protein
    Sujet
    BCMA is a receptor for BAFF and APRIL. It promotes B cell survival and plays a role in the regulation of humoral immunity. Its downstream signaling is dependent on NF-kappaB and JNK.
    Poids moléculaire
    ~40kDa (SDS-PAGE)
    UniProt
    Q02223
Vous êtes ici:
Support technique